Psychiatrie - Sekce poruchy příjmu potravy
Psychiatrie - Sekce poruchy příjmu potravy
Psychiatrie - Sekce poruchy příjmu potravy
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
30<br />
Abstrakta<br />
nistrovány elektronicky prostřednictvím softwaru<br />
Web-Akquasi vyvinutého Centrem pro<br />
výzkum v psychoterapii Univerzity Heidelberg.<br />
Design studie znázorňuje tabulka 1.<br />
Výsledky: V našem sdělení prezentujeme<br />
první výsledky studie se zaměřením na neuropsychologické<br />
charakteristicky pacientů<br />
(srovnání visuoprostorové organizace a paměti<br />
a centrální koherence na začátku a na konci<br />
hospitalizace a mezi pacientkami s mentální<br />
anorexií, bulimií a zdravými kontrolami).<br />
Podpořeno VZ 21620816 a projektem INTACT<br />
(MRTN-CT-2006-035988)<br />
Literatura<br />
1. Bauer S, Winn S, Schmidt U, Kordy H. Construction, scoring<br />
and validation of the Short Evaluation of Eating Disorders<br />
(SEED), European Eating Disorders Review. 2005; 13:<br />
191–200.<br />
2. Claes L, Vandereycken W. The Self-Injury Questionnaire-<br />
Treatment Related (SIQ-TR): Construction, reliability, and validity<br />
in a sample of female eating disorder patients. In P.M. Goldfarb<br />
(Ed.), Psychological Tests and Testing Research Trends,<br />
111–139, New York: Nova Science Publishers.<br />
3. Cloninger CR. A systematic Metod for clinical description<br />
and classifi cation of personality variants. A proposal. Arch<br />
Gen Psychiatry. 1987; 44(6): 537–588.<br />
4. Fairburn CG, Beglin SJ. Assessment of eating disorders: interview<br />
or self-report questionnaire? Int J Eat Disord. 1994;<br />
16(4): 363–370.<br />
5. Goodman WK, Price LH, Rasmusse SA, Mazure C,<br />
Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-<br />
Brown Obsessive Compulsive Scale, I., Developmenrt, use<br />
and reliability. Arch Gen Psychiatry. 1989; 46(11).<br />
6. Lopez C, Tchanturia K, Stahl D, Booth R, Holliday J, Treasure<br />
J. An Examination of the Concept of Central Coherence<br />
in Women with Anorexia Nervosa. Int J Eat Disord. 2008;<br />
41(2): 143–152.<br />
7. Moessner M, Bauer S, Fassnacht D, Kordy H. Construction<br />
and Validation of the Clinical and Research Inventory for Eating<br />
Disorders (CR-EAT). Manuscript in preparation.<br />
8. Osterrieth PA. Le test de copie d´une fi gure complex: Contribution<br />
a l´etude de la perception et de la memoire. Archives<br />
de Psychologie. 1944; 30: 286–356.<br />
9. Rieger E, Touyz SW, Beumont PJ. The Anorexia Nervosa<br />
Stages of Change Questionnaire (ANSOCQ): Information<br />
Regarding its Psychometric Properties. Int J Eat Disord.<br />
2002; 32(1): 24–38.<br />
Proteiny tukové tkáně<br />
a inzulinová senzitivita<br />
Insulin sensitivity<br />
and proteins of the fat tissue<br />
Horáková D., Kollárová H., Pastucha D.,<br />
Janoutová G., Janout V.<br />
Ústav preventivního lékařství LF UP,<br />
Olomouc. Department of Preventive Medicine<br />
Faculty of Medicine, Palacky University,<br />
Olomouc<br />
Souhrn: Inzulinová rezistence je velmi sledovaným<br />
jevem v patogeneze metabolického<br />
syndromu. Podílí se na rozvoji diabetu 2. typu,<br />
obezity, hytertenze, akceleruje aterosklerózu. Je<br />
Tabulka. Design Studie<br />
Začátek hospitalizace<br />
Monitoring<br />
á 7 dnů<br />
studována aktivita tukové tkáně, která je zdrojem<br />
proteinů adiponektinu a aFABP, ovlivňujících<br />
senzitivitu cílových tkání na inzulin. Na souboru<br />
pacientů s projevy inzulinové rezistence a skupině<br />
zdravých jedinců byly měřeny koncentrace<br />
adiponektinu a aFABP a stanoveny korelace<br />
s ostatními metabolickými parametry, včetně<br />
homeostatických indexů. Závěry ukazují, že<br />
adiponektin může být vhodným biomarkerem<br />
stavu inzulinové senzitivity v organizmu.<br />
Summary: Concentrations of adiponectine<br />
and aFABP were measured in a group of patients<br />
with insuline resistency and healthy controls.<br />
Correlations with other metabolic parameters including<br />
other homeostatic indices were calculated. The<br />
results show that adiponectine can be a biomarker<br />
of insulin sensitivity.<br />
Biomarkers of Anorexia Nervosa<br />
Biologické markery anorexia nervosa<br />
Sietske G. Helder, Ricardo Sainz-Fuertes, Frederique<br />
Van den Eynde, Anna V. Oldershaw,<br />
Janet Treasure, Iain C. Campbell, Simon Lovestone,<br />
Ulrike H. Schmidt, David A. Collier<br />
Social, Genetic and Developmental Psychiatry<br />
Research Centre, Eating Disorders<br />
Section, MRC Centre for Neurodegeneration<br />
Research, Institute of Psychiatry, King’s<br />
College London, London, UK<br />
Anorexia Nervosa (AN) is characterized by<br />
below normal weight and persistent fear of<br />
weight gain, as well as obsessive-compulsive,<br />
harm-avoidant and anxious traits. It has high<br />
levels of mortality and disability and early<br />
identification of high risk cases is crucial to<br />
prevent these negative outcomes. There is<br />
also a need to better understand causal and<br />
maintaining factors of all subtypes of AN, in<br />
order to improve and tailor treatment. There<br />
is growing evidence that altered neurobiology<br />
significantly contributes to the pathogenesis<br />
of AN. Gene association, candidate protein and<br />
neuroimaging studies have already pointed<br />
Konec hospitalizace<br />
VII. Mezioborová konference o poruchách <strong>příjmu</strong> <strong>potravy</strong> a obezitě s mezinárodní účastí | 19. – 21. 3. 2009<br />
Follow-up<br />
á 1 měsíc<br />
Follow-up po<br />
6 měsících<br />
Poslední follow-up<br />
(6–18<br />
měsíců)<br />
EDE-Q (symptomy PPP) X X X X X X<br />
SEED (symptomy PPP) X X X X X X<br />
CR-EAT (symptomy PPP) X X X X X X<br />
Y-BOCS (OCD symptomy) X X X X<br />
SIQ-TR (sebezraňování) X X X X X X<br />
ANSOCQ (motivace k léčbě) X X X X<br />
RCFT (prostorová paměť a organizace) X X<br />
TPQ (osobnost) X<br />
out systems that may be involved in AN, such<br />
as serotonin and dopamine. But because most<br />
methods tend to only look at one molecule at<br />
a time, there is still little understanding of the<br />
complexity and interactions of the systems.<br />
We conducted a proteome-wide analysis of<br />
AN, aimed at identifying new protein biomarkers<br />
of the disease. Biomarkers are useful in<br />
aetiological studies and have potential for<br />
translation to clinical management of patients.<br />
Once validated, they can be used to monitor<br />
disease course and severity, to tailor treatment<br />
or to predict onset, relapse, treatment<br />
response or outcome.<br />
We will present an overview of the first<br />
results of a pilot study comparing current<br />
AN patients to recovered AN patients and<br />
healthy controls. Blood plasma was analyzed<br />
by two-dimensional gel electrophoresis, using<br />
methods that have proved useful in proteomic<br />
studies of Alzheimer’s disease. We are<br />
following up these results in a longitudinal<br />
case-only study.<br />
Supported by INTACT (MRTN-CT-2006-035988)<br />
Genotypes and phenotypes in<br />
anorexia nervosa<br />
Genotypy a fenotypy u anorexia nervosa<br />
Marek Brandys, Judith Hendriks, Unna Danner,<br />
Annemarie van Elburg, Roger Adan<br />
Rudolf Magnus<br />
Institute of Neuroscience, Dept. of Neuroscience<br />
and Pharmacology, University<br />
Medical Center Utrecht, The Netherlands,<br />
Rintveld Centre for Eating Disorders, Altrecht<br />
Mental Health Institute, Zeist, The Netherlands,<br />
Dept. of Clinical & Health Psychology,<br />
Utrecht University, The Netherlands<br />
Anorexia nervosa (AN) is a psychiatric disease<br />
with a well-documented heritability. The mechanisms<br />
of genetic susceptibility to AN remain largely<br />
unknown. In this study we begin with determining<br />
associations of candidate genes to the disease